ResearcherSouth Texas Veterans Health Care SystemNo recent work listed

Susan M Fischer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8594-7882; OpenAlex author ID A5113913633; NIH RePORTER profile ID 1889457. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 2
Labs led: 1
Collaborators: 9

Papers, trials and grants by year

2011: 1 paper · 2012: 2 grants · 2013: 1 paper · 2014: 1 paper

Papers 3

Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-13-1664 ↗
Dietary energy balance modulation of Kras- and Ink4a/Arf+/--driven pancreatic cancer: the role of insulin-like growth factor-I. Co-author DOI 10.1158/1940-6207.capr-13-0185 ↗
Rapamycin partially mimics the anticancer effects of calorie restriction in a murine model of pancreatic cancer. Co-author DOI 10.1158/1940-6207.capr-11-0023 ↗

Grants 2

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Laura M. Lashinger · 2 shared papers, 2011–2013 · strength 0.07
- Paper Dietary energy balance modulation of Kras- and Ink4a/Arf+/--driven pancreatic cancer: the role of insulin-like growth f… DOI 10.1158/1940-6207.capr-13-0185 ↗
- Paper Rapamycin partially mimics the anticancer effects of calorie restriction in a murine model of pancreatic cancer. DOI 10.1158/1940-6207.capr-11-0023 ↗
Stephen D Hursting · 2 shared papers, 2011–2013 · strength 0.07
- Paper Dietary energy balance modulation of Kras- and Ink4a/Arf+/--driven pancreatic cancer: the role of insulin-like growth f… DOI 10.1158/1940-6207.capr-13-0185 ↗
- Paper Rapamycin partially mimics the anticancer effects of calorie restriction in a murine model of pancreatic cancer. DOI 10.1158/1940-6207.capr-11-0023 ↗
Craig D. Logsdon · 1 shared paper, 2013 · strength 0.04
- Paper Dietary energy balance modulation of Kras- and Ink4a/Arf+/--driven pancreatic cancer: the role of insulin-like growth f… DOI 10.1158/1940-6207.capr-13-0185 ↗
James W. Freeman · 1 shared paper, 2014 · strength 0.04
- Paper Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer. DOI 10.1158/1078-0432.ccr-13-1664 ↗
Addanki Pratap Kumar · 1 shared paper, 2014 · strength 0.04
- Paper Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer. DOI 10.1158/1078-0432.ccr-13-1664 ↗
Divya Chakravarthy · 1 shared paper, 2014 · strength 0.04
- Paper Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer. DOI 10.1158/1078-0432.ccr-13-1664 ↗
Jingjing Gong · 1 shared paper, 2014 · strength 0.04
- Paper Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer. DOI 10.1158/1078-0432.ccr-13-1664 ↗
Huamin Wang · 1 shared paper, 2014 · strength 0.04
- Paper Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer. DOI 10.1158/1078-0432.ccr-13-1664 ↗
Scott Kopetz · 1 shared paper, 2014 · strength 0.04
- Paper Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer. DOI 10.1158/1078-0432.ccr-13-1664 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.